Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity
- PMID: 18990675
- PMCID: PMC2633055
- DOI: 10.1164/rccm.200804-608OC
Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity
Erratum in
- Am J Respir Crit Care Med. 2009 Nov 1;180(9):910-1
Abstract
Rationale: Obstructive sleep apnea is associated with insulin resistance and liver injury. It is unknown whether apnea contributes to insulin resistance and steatohepatitis in severe obesity.
Objectives: To examine whether sleep apnea and nocturnal hypoxemia predict the severity of insulin resistance, systemic inflammation, and steatohepatitis in severely obese individuals presenting for bariatric surgery.
Methods: We performed sleep studies and measured fasting blood glucose, serum insulin, C-reactive protein, and liver enzymes in 90 consecutive severely obese individuals, 75 women and 15 men, without concomitant diabetes mellitus or preexistent diagnosis of sleep apnea or liver disease. Liver biopsies (n = 20) were obtained during bariatric surgery.
Measurements and main results: Obstructive sleep apnea with a respiratory disturbance index greater than 5 events/hour was diagnosed in 81.1% of patients. The median respiratory disturbance index was 15 +/- 29 events/hour and the median oxygen desaturation during apneic events was 4.6 +/- 1.8%. All patients exhibited high serum levels of C-reactive protein, regardless of the severity of apnea, whereas liver enzymes were normal. Oxygen desaturation greater than 4.6% was associated with a 1.5-fold increase in insulin resistance, according to the homeostasis model assessment index. Histopathology data suggested that significant nocturnal desaturation might predispose to hepatic inflammation, hepatocyte ballooning, and liver fibrosis. Fasting blood glucose levels and steatosis scores were not affected by nocturnal hypoxia. There was no relationship between the respiratory disturbance index and insulin resistance or liver histopathology.
Conclusions: Hypoxic stress of sleep apnea may be implicated in the development of insulin resistance and steatohepatitis in severe obesity.
Figures
![<b>Figure 1.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2633055/bin/AJRCCM1793228f1.gif)
![<b>Figure 2.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2633055/bin/AJRCCM1793228f2.gif)
![<b>Figure 3.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2633055/bin/AJRCCM1793228f3.gif)
Comment in
-
Indices of hypoxic stress in sleep apnea.Am J Respir Crit Care Med. 2009 Nov 1;180(9):910; author reply 910-1. doi: 10.1164/ajrccm.180.9.910a. Am J Respir Crit Care Med. 2009. PMID: 19843828 No abstract available.
Similar articles
-
Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.Am J Respir Crit Care Med. 2014 Jan 1;189(1):66-76. doi: 10.1164/rccm.201307-1339OC. Am J Respir Crit Care Med. 2014. PMID: 24256086
-
Anaesthesia in obese patients.Br J Hosp Med (Lond). 2011 Sep;72(9):515-20. doi: 10.12968/hmed.2011.72.9.515. Br J Hosp Med (Lond). 2011. PMID: 22041833 Review. No abstract available.
-
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.J Hepatol. 2012 Jan;56(1):225-33. doi: 10.1016/j.jhep.2011.04.022. Epub 2011 May 19. J Hepatol. 2012. PMID: 21703181
-
Chronic liver injury during obstructive sleep apnea.Hepatology. 2005 Jun;41(6):1290-6. doi: 10.1002/hep.20725. Hepatology. 2005. PMID: 15915459
-
Sleep apnea is a manifestation of the metabolic syndrome.Sleep Med Rev. 2005 Jun;9(3):211-24. doi: 10.1016/j.smrv.2005.01.006. Sleep Med Rev. 2005. PMID: 15893251 Review.
Cited by
-
Potential Therapeutic Targets in Obesity, Sleep Apnea, Diabetes, and Fatty Liver Disease.J Clin Med. 2024 Apr 12;13(8):2231. doi: 10.3390/jcm13082231. J Clin Med. 2024. PMID: 38673503 Free PMC article. Review.
-
Duration of intermittent hypoxia impacts metabolic outcomes and severity of murine NAFLD.Front Sleep. 2023;2:1215944. doi: 10.3389/frsle.2023.1215944. Epub 2023 Aug 25. Front Sleep. 2023. PMID: 38077744 Free PMC article.
-
Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review.Int J Obes (Lond). 2023 Dec;47(12):1200-1213. doi: 10.1038/s41366-023-01378-2. Epub 2023 Sep 11. Int J Obes (Lond). 2023. PMID: 37696927 Free PMC article. Review.
-
Insulin Resistance, but Not Obstructive Sleep Apnea Is Associated with Hepatic Steatosis in Chinese Patients with Severe Obesity.Obes Facts. 2023;16(4):344-355. doi: 10.1159/000528789. Epub 2023 Feb 28. Obes Facts. 2023. PMID: 36854279 Free PMC article.
-
The role of platelet-related parameters for the prediction of NAFLD in OSAHS patients.BMC Pulm Med. 2022 Dec 24;22(1):487. doi: 10.1186/s12890-022-02291-6. BMC Pulm Med. 2022. PMID: 36566219 Free PMC article.
References
-
- American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667–689. - PubMed
-
- Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156–162. - PubMed
-
- Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002;165:677–682. - PubMed
-
- Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004;160:521–530. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials